Location History:
- Port Jefferson, NY (US) (1989 - 1993)
- Hingham, MA (US) (1992 - 1996)
- Center Valley, PA (US) (1999)
Company Filing History:
Years Active: 1989-1999
Title: Herbert C Hoover, Jr: Innovator in Cancer Therapy
Introduction
Herbert C Hoover, Jr. is a notable inventor based in Hingham, MA (US), recognized for his significant contributions to cancer therapy. He holds a total of 8 patents, showcasing his dedication to advancing medical science and improving patient outcomes.
Latest Patents
Among his latest inventions is the patent for Tumor Associated Epitope. This invention relates to the epitopes to which monoclonal antibody 88BV59 and antibody 16.88 react. These antibodies were produced by B-cell lines derived from cancer patients who were actively immunized with autologous tumor antigens. Both epitopes are found on the same antigen in tumor tissue. These epitopes can be utilized in both diagnostic procedures and therapy for human cancers. Another significant patent is for Active Specific Immunotherapy. This invention outlines a method of cancer therapy for treating human patients with resectable solid tumors to inhibit recurrence and formation of metastases. The process involves surgically removing tumor tissue, treating it to obtain tumor cells, irradiating the tumor cells to ensure they are viable but non-tumorigenic, preparing a vaccine, and injecting it intradermally into the patient after their immune system has recovered from surgery.
Career Highlights
Herbert has worked with prominent companies such as Akzo N.V. and Akzo Nobel N.V., where he has applied his innovative ideas to real-world challenges in the medical field. His work has had a lasting impact on cancer treatment methodologies.
Collaborations
Throughout his career, Herbert has collaborated with notable individuals, including Michael G Hanna, Jr. and Martin V Haspel. These partnerships have contributed to the development of his groundbreaking inventions.
Conclusion
Herbert C Hoover, Jr. stands out as a pioneering inventor in the field of cancer therapy, with a focus on innovative solutions that enhance patient care. His contributions continue to influence the medical community and offer hope for improved cancer treatment options.